Mucinex, Tylenol, Sudafed PE, Robitussin, Theraflu, Vicks, and Other Cold and Flu Medicines
Allegations: Falsely marketing that medicines treat nasal congestion
Robitussin Non-Drowsy Claims
Case Name (Date)
Papalia et al. v GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
22-cv-2630, S.D.N.Y.
(March 2022)
Product/Service
Robitussin
Allegations
Falsely marketing products as non-drowsy when an ingredient (dextromethorphan, or DXM) in them causes drowsiness
Status
Pending
Class-Action Tracker
Robitussin naturals Cough Relief – Honey and Ivy Leaf
Allegations: Misleadingly marketing the ingredients in and the health benefits provided by products
Sudafed PE, Tylenol Cold & Flu Severe, Benadryl Allergy Plus, Theraflu, NyQuil Severe Cold & Flu, and Walgreens
Allegations: Falsely marketing medicines as decongestants
Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, Robitussin, and Other Cold and Flu Medicines
Allegations: Falsely marketing that medicines treat congestion
Tylenol, TheraFlu, Mucinex, and Several Store Brands of Cold and Flu Medicines
Allegations: Falsely marketing medicines as nasal decongestants
Sudafed, NyQuil, Theraflu, Robitussin, Tylenol, Mucinex, and Several Store-brand Cold and Flu Medicines
Allegations: Falsely marketing medicines as nasal decongestants
Theraflu, Sudafed, Tylenol, and other Cold & Flu Medicines
Allegations: Falsely marketing medicines as decongestants
Sudafed, Tylenol, and Other Cold and Flu Medicines
Allegations: Falsely marketing products as decongestants
Robitussin Cough Medicine with DXM
Allegations: Falsely marketing medicine as “Non-Drowsy” when the active ingredient causes drowsiness
ChapStick Products
Allegations: False natural claims
Abreva
Allegations: Misleadingly marketing Abreva cold sore treatments
ChapStick Natural Claims
In December 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare Holdings and Pfizer for allegedly falsely advertising ChapStick products as natural when, according to plaintiffs, the products contain…
Benefiber Prebiotic Supplement
In August 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare for allegedly misleadingly advertising Benefiber Prebiotic Supplement as “100% Natural” when, according to plaintiffs, the company uses a…
Boostrix
In May 2020, a class-action lawsuit was filed against GlaxoSmithKline for allegedly falsely advertising the medication Boostrix in what has been referred to as “The Big Bad Cough” advertising campaign.…
Total Hydration ChapStick
December 2018: This case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. September 2016: A class-action…
Chapstick Lip Balms with Sunscreen
In May 2019, a class-action lawsuit was filed against Wyeth Consumer Healthcare for allegedly misleadingly marketing – on the front of the package — that its Chapstick lip balm-sunscreen products…
The Latest
CATrends: OTC Cold and Flu Medicines Falsely Marketed as ‘Non-Drowsy’
Several products marketed as ‘non-drowsy’ contain an ingredient that causes drowsiness, lawsuits claim.
ChapStick Moisturizer
Lip balm’s own directions seem to contradict its “8 Hour Moisture” labeling claim.
Bagging Claims by Unofficial Oscar Swag Companies
Cue the play-off music.
The Lowdown on Low T
Is Big Pharma marketing a drug to help aging men with low sex drives or really selling a made-up disease?
Happy, Horny, Skinny Pill?
GSK will pay out $105 million in off-label use case.